In addition to its expertise, the company uses a cloud-based tracking system that allows sponsors and CROs read-only access to monitor the status of contract negotiations in real-time.
CEO Brandon Evans, former head of legal services at PRA Health Sciences, told Outsourcing-Pharma.com that Clintrax saves companies an average of 40% on the time it takes to start a clinical trial -- typically 45 days for a CRO in the US.
“CROs aren’t really interested in contract negotiations,” Evans told us, adding that it’s mostly because they aren’t good at negotiating with sites and it’s not a money maker for them.
And when CROs and sponsors do negotiate with trial site investigators, especially in foreign countries, it’s usually local CRAs (clinical research associates) that do the negotiating, though they often don’t understand the legal nuances of the contract they’re working on, Evans said.
“Ninety-seven percent of our staffers are lawyers,” Evans added, noting that contract negotiations are easier in the US and Canada, and considerably more difficult and complex in France, Poland and Hungary, though the therapeutic area also plays a role.